BackBelite Bio Overview

Belite Bio Current Assets

Latest current assets for BLTE: $500M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$501.60M
↑ 232.25% YoYΔ $350.63M vs prior year quarter

Peer trimmed avg / median

Loading

Belite Bio Current Assets History

Loading

Belite Bio vs. peers: Current Assets Comparison

Loading

Belite Bio Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Belite Bio (BLTE) FAQ

As of the most recent data (June 2026), BLTE shows a current assets of $500M. That compares with $150M in the prior-year period — up 232.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLTE's current assets is now $500M (was $150M) — a 232.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Belite Bio is outperforming or lagging.

Tracking BLTE's current assets over time shows whether Belite Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $500M That compares with $150M in the prior-year period — up 232.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Belite Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $500M) with ownership activity and broader fundamentals.